CADL
Companies
NASDAQ
Candel Therapeutics Inc.
Health Care
$4.85
-$3.83 (-44.12%)
Price Chart
Overview
About CADL
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
Market Cap
$212.8M
Volume
6.1M
Avg. Volume
5.5M
P/E Ratio
-5.3186812
Dividend Yield
0.00%
Employees
65.0
Company Information
Risk & Correlation Analysis
Market Correlation
0.72
Low Correlation
Volatility
High (1.00)
Relative to market
Macro Factor Sensitivities
Interest Rates
Low Sensitivity
Inflation
High Sensitivity
GDP Growth
High Sensitivity
Liquidity
High Sensitivity
Commodity Prices
High Sensitivity
Credit Quality
High Sensitivity
Portfolio Impact
Forecasts & Predictions
1-Month Target
$XXX.XX
+X.X% Potential
3-Month Target
$XXX.XX
+X.X% Potential
12-Month Target
$XXX.XX
+X.X% Potential
Technical Analysis
Based on technical indicators and chart patterns, CADL shows...
AI Sentiment Analysis
Market sentiment analysis indicates...
Key Statistics
Market Cap$212.8M
Volume6.1M
P/E Ratio-5.32
Dividend Yield0.00%
Important Dates
Next Dividend
Next Earnings
May 11, 2023Related Securities
Pricing info last updated June 19, 2025 (after market close)Other info last updated April 2, 2025